Figures & data
Table 1. Patient characteristics.
Figure 1. (A) Relative expression of miR-124 in tumour tissues and normal adjacent tissues of 112 HCC patients. (B) Overall survival rate of high miR-124 expression patients and low miR-124 expression patients. Kaplan–Meier analysis was used for the statistical assessment.
![Figure 1. (A) Relative expression of miR-124 in tumour tissues and normal adjacent tissues of 112 HCC patients. (B) Overall survival rate of high miR-124 expression patients and low miR-124 expression patients. Kaplan–Meier analysis was used for the statistical assessment.](/cms/asset/b8a29fc3-c77c-4a30-86ea-dc36b0bf6979/ianb_a_1415918_f0001_c.jpg)
Table 2. The relationship between clinicopathological characteristics and overall survival of patients.
Figure 3. (A) Western blot and quantization of KLF4, RAB11FIP4 and RAF1 in SMMC-7221 transfected with miR-124 mimics. (B) Luciferase assay was used to confirm the targetability of KLF4 3′ UTR and miR-124. Wild type represent bona fide sequence of KLF4 3′ UTR; Mutant represents a sequence mimicking the KLF4 3′ UTR, but introduced with four single nucleotide variant.
![Figure 3. (A) Western blot and quantization of KLF4, RAB11FIP4 and RAF1 in SMMC-7221 transfected with miR-124 mimics. (B) Luciferase assay was used to confirm the targetability of KLF4 3′ UTR and miR-124. Wild type represent bona fide sequence of KLF4 3′ UTR; Mutant represents a sequence mimicking the KLF4 3′ UTR, but introduced with four single nucleotide variant.](/cms/asset/294b22eb-0503-4a3c-8bb9-06d8c4d5b4cc/ianb_a_1415918_f0003_b.jpg)